Global Point of Care
ID NOW™ provides rapid molecular testing results for COVID-19, Influenza A & B, RSV or Strep A right at the Point of Care.
ID NOW™ Provides Rapid Molecular Testing Results for COVID-19, Influenza A & B, RSV or Strep A right at the Point of Care.
The ID NOW offers full flexibility to test for COVID-19, Influenza A & B, RSV or Strep A on a single platform and with accuracy equivalent to conventional RT-PCR. For even more flexibility, you can run both COVID-19 and Influenza A & B tests using the same patient swab.
With the ID NOW platform, you have the power to decide which tests to run based on patient presentation, circulating prevalence, and seasonality. By reducing unnecessary testing, you can save time and money while increasing diagnostic accuracy in low-prevalence situations.
The ID NOW platform can help you to recentralize diagnostic testing around the patient to deliver fast actionable results at any bay or bedside. With a small footprint, the platform can be placed anywhere, allowing near-patient testing or triaging. The availability of bedside testing empowers you to improve patient management. With results being available in just 2-13 minutes, you are empowered to make decisions during the first patient examination.
Learn how the ID NOW platform can improve patient management with rapid, flexible testing at the patient bedside. Biomedical Scientist Yusuf Gray explains the benefits of testing for multiple respiratory illnesses on one platform.
Designed for intuitive use, the ID NOW platform integrates easily into your workflow and transforms a complex procedure into a simple one. Operational features include on-screen guidance for every step enabling complete ease of use.
ID NOW requires minimal training to operate. And with our online platform myPOCtutor, on-demand training is available anytime, anywhere. So you can stay up-to-date with a wide range of accessible online or face-to-face training courses, assessments, and certifications.
ID NOW is simple to use and helps teams to identify patient pathways quickly. Miriam Boyack, Lead Nurse, Infection Prevention and Control, at Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trusts shares how easy ID NOW is to use.
A LEADER IN RAPID POINT-OF-CARE DIAGNOSTICS.
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.
